ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Precision BioSciences, Inc. ?
1
Poor long term growth as Operating profit has grown by an annual rate 8.81% of over the last 5 years
2
With a growth in Net Profit of 38.83%, the company declared Very Positive results in Jun 26
- The company has declared positive results for the last 3 consecutive quarters
- NET SALES(HY) At USD 10.84 MM has Grown at 22,959.57%
- OPERATING CASH FLOW(Y) Highest at USD -46.98 MM
- NET PROFIT(HY) Higher at USD -26.9 MM
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 30.33%, its profits have fallen by -142.5%
4
High Institutional Holdings at 90.68%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 12.78% over the previous quarter.
5
Market Beating Performance
- The stock has generated a return of 30.33% in the last 1 year, much higher than market (S&P 500) returns of 15.76%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Precision BioSciences, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Precision BioSciences, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Precision BioSciences, Inc.
23.39%
-0.67
71.34%
S&P 500
16.06%
1.20
13.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
7.12%
EBIT Growth (5y)
8.81%
EBIT to Interest (avg)
-50.75
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.08
Sales to Capital Employed (avg)
0.67
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
77.90%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.62
EV to EBIT
-1.10
EV to EBITDA
-1.16
EV to Capital Employed
57.34
EV to Sales
1.67
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-5214.80%
ROE (Latest)
-59.66%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend18What is working for the Company
NET SALES(HY)
At USD 10.84 MM has Grown at 22,959.57%
OPERATING CASH FLOW(Y)
Highest at USD -46.98 MM
NET PROFIT(HY)
Higher at USD -26.9 MM
RAW MATERIAL COST(Y)
Fallen by -99.97% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at -131.25 %
-1What is not working for the Company
DEBTORS TURNOVER RATIO(HY)
Lowest at 0 times
Here's what is working for Precision BioSciences, Inc.
Net Sales
At USD 10.84 MM has Grown at 22,959.57%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (USD MM)
Net Profit
Higher at USD -26.9 MM
than preceding 12 month period ended Jun 2026MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Operating Cash Flow
Highest at USD -46.98 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Debt-Equity Ratio
Lowest at -131.25 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -99.97% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Precision BioSciences, Inc.
Debtors Turnover Ratio
Lowest at 0 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Footer loading
